An AI Invasion: Improving Breast Cancer Biopsies
Researchers report the first-ever routine clinical use of an AI-based tool for breast cancer biopsies in a pathology lab.
Diagnostic Testing and Emerging Technologies
LAB COMPLIANCE ADVISOR
LAB INDUSTRY REPORT
NATIONAL LAB REPORTER
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
Researchers report the first-ever routine clinical use of an AI-based tool for breast cancer biopsies in a pathology lab.
More companies have begun offering neurofilament light chain blood tests as a cost-effective alternative to conventional methods.
The test manufacturer is the first to gain IVDR certification for a companion diagnostic under the new regulation.
A recent CDC report concludes that disruptions to HIV testing due to the COVID-19 pandemic compromised America’s ability to prevent the disease.
In this month’s diagnostics pipeline report, Roche gets clearance for two new Alzheimer’s early detection tests.
According to a recent OIG report, fewer Medicare Part B beneficiaries received lab tests during the first 10 months of the pandemic.
Circulating tumor DNA sequencing technologies are tackling the challenges of early cancer detection.
Advances in MALDI time-of-flight mass spectrometry have significantly expanded its use in high-throughput diagnostic labs.
Researchers have identified 35 genes found in high expression in people with long-term Lyme disease, which could lead to earlier detection.
A new test targeting changes in serum proteins can detect breast cancer up to two years before the condition would normally be diagnosed.
Saliva testing for the virus that causes COVID-19 is gaining acceptance in both the scientific community and US market.